Tricuspid Regurgitation: Clinical Trials

2 trials for Tricuspid Regurgitation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 2

Follow Tricuspid Regurgitation: new trials by email Literature Review of Tricuspid Regurgitation trials Research Report on Tricuspid Regurgitation

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Safety and Efficacy of Tolvaptan for Patients With Tricuspid Regurgitation and Right Heart Failure After Left Heart Valves Replacement
tolvaptan+torasemide, placebo+torasemide - Tricuspid Regurgitation, Right Heart Failure
Phase 4CompletedShanghai Chest Hospital402014-11-012016-12-20
Tricuspid Regurgitation Study
Echo - Tricuspid Regurgitation, Right Ventricular Dysfunction
Phase 4CompletedMayo Clinic1192010-05-012016-11-03

Narrower conditions

Tricuspid Valve Insufficiency (2)  ·  Heart Failure (1)  ·  Ventricular Dysfunction, Left (1)  ·  Ventricular Dysfunction, Right (1)

Broader conditions

Cardiovascular Diseases (2)  ·  Heart Diseases (2)  ·  Heart Valve Diseases (2)  ·  Ventricular Dysfunction (1)

Interventions

Caves (1)

Sponsors

Mayo Clinic (1)  ·  Shanghai Chest Hospital (1)

Countries

China (1)  ·  United States (1)

Top investigators

Fang Yuan (1)  ·  Yong-Mei Cha, MD (1)

Results publications

PMID 30255476